Clinical Trials
73 trialsPRSTEC_multipr
University Hospital Hradec Kralove
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
AstraZeneca
Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding
University of Aarhus
DUOLife
AstraZeneca
iCaRe2
University of Nebraska
DP-04
AstraZeneca
ENDOCancerDATA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
REPLACE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
LYNX-EYE
San Raffaele University
ENVISION
Exact Sciences Corporation
ECHO
Mayo Clinic
DETECTR
University of British Columbia
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
Mayo Clinic
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Memorial Sloan Kettering Cancer Center
ASAP
Avera McKennan Hospital & University Health Center
(CLOCS-2)
Imperial College London
ELEPHAS-04
Mayo Clinic
Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study
Tata Memorial Hospital
Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer
M.D. Anderson Cancer Center
IREN
AstraZeneca
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
Mayo Clinic
ESG-ENDO
Centro di Riferimento Oncologico - Aviano
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
University Hospital Tuebingen
DOSTCONICG
Cukurova University
SMARAGD
iOMEDICO AG
The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study
University of Aarhus
CAMPERR
Adela, Inc
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
M.D. Anderson Cancer Center
ELEPHAS-05
Elephas
organoids endo
Regina Elena Cancer Institute
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
ECS Weight
University of Kansas Medical Center
The Better, Harder, Faster, Stronger Study
Wake Forest University Health Sciences
DOvEEgene Fleur: New Uterine Sampling Tool
McGill University
Application of da Vinci SP for Endometrial Cancer Surgical Staging
National Cancer Institute, Naples
DETECT
University of Alabama at Birmingham
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Weill Medical College of Cornell University
Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations
MiMARK Diagnostics, S.L.
RWS-MTB
Sun Yat-sen University
ORACLE
Guardant Health, Inc.
The Role of POLE Mutation in High Risk Endometrial Cancer.
Far Eastern Memorial Hospital
CHOICE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
Mayo Clinic
A Cohort Study of Uterine Malignancies
Women's Hospital School Of Medicine Zhejiang University
TJ Intrauterin
Tongji Hospital
DOvEEgene
McGill University
RHINOCERUS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
BARHYSTER
Aesculap AG
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
Peking University People's Hospital
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
National Cancer Institute, Naples